Expression of the GLUT1 glucose transporter, p63 and p53 in thyroid carcinomas

Pathology Research and Practice

Volumn 202, Issue 11, 2006, Pages 759-765

  Kim, Youn Wha ^a   Do, In Gu ^a   Park, Yong Koo ^a  

^a Kyung Hee University Hospital   (South Korea)

Author keywords

GLUT1; p53; p63; Thyroid carcinoma

Indexed keywords

GLUCOSE TRANSPORTER 1; PROTEIN P53; PROTEIN P63;

ADOLESCENT; ADULT; AGED; ANAPLASTIC CARCINOMA; ARTICLE; BASAL CELL; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FOLLICULAR CARCINOMA; HUMAN; HYPOXIA; MAJOR CLINICAL STUDY; MALE; PAPILLARY CARCINOMA; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SCHOOL CHILD; SIGNAL TRANSDUCTION; STEM CELL; THYROID CARCINOMA;

EID: 33750040233     PISSN: 03440338     EISSN: 16180631     Source Type: Journal    
DOI: 10.1016/j.prp.2006.07.006     Document Type: Article

References (26)

1. Birnbaum M.J., Haspel H.C., and Rosen O.M. Transformation of rat fibroblasts by FSV rapidly increases glucose transporter gene transcription. Science 235 (1987) 1495-1498
2. Chandler J.D., Williams E.D., Slavin J.L., Best J.D., and Rogers S. Expression and localization of GLUT1 and GLUT12 in prostatic carcinoma. Cancer 97 (2003) 2035-2042
3. Chang S.G., Lee S.J., Lee C.H., Kim J.I., and Kim Y.W. Expression of the human erythrocyte glucose transporter in transitional cell carcinoma of the bladder. Urology 55 (2000) 448-452
4. Choi H.R., Batsakis J.G., Zhan F., Sturgis E., Luna M.A., and El-Naggar A.K. Differential expression of p53 gene family members p63 and p73 in head and neck squamous tumorigenesis. Hum. Pathol. 33 (2002) 158-164
5. R.A. DeLellis, R.V. Lloyd, P.U. Heitz, C. Eng, Pathology and genetics tumours of endocrine organs, in: WHO Classification of Tumours, IARC Press, Lyon, 2004, pp. 57-91.
6. Haber R.S., Rathan A., Weiser K.R., Pritsker A., Itzkowitz S.H., Bodian C., Slater G., Weiss A., and Burnstein D.E. GLUT1 glucose transporter expression in colorectal carcinoma. Cancer 83 (1998) 34-40
7. Haber R.S., Weiser K.R., Pritsker A., Reder I., and Burstein D.E. GLUT1 glucose transporter expression in benign and malignant thyroid nodules. Thyroid 7 (1997) 363-367
8. M.T. Idrees, B.Y. Wang, P.D. Unger, L. Gan, D.E. Burstein, p63 and GLUT-1 expression in anaplastic thyroid carcinoma, Mod. Pathol. 17 (Abstract) 225A.
9. Isselbach K.J. Sugar and amino acid transport by cells in culture-differences between normal and malignant cells. N. Engl. J. Med. 286 (1972) 929-933
10. Ivan D., Diwan A.H., and Prieto V.G. Expression of p63 in primary cutaneous adnexal neoplasms and adenocarcinoma metastatic to the skin. Mod. Pathol. 18 (2005) 137-142
11. Kim Y.W., Park Y.K., Yoon T.Y., and Lee S.M. Expression of the GLUT1 glucose transporter in gallbladder carcinomas. Hepato-Gastroenterology 49 (2001) 907-911
12. Levrero M., De Laurenzi V., Costanzo A., Gong J., Wang J.Y., and Melino G. The p53/p63/p73 family of transcription factors: overlapping and distinct functions. J. Cell Sci. 113 (2000) 1661-1670
13. Malaguarnera R., Mandarino A., Mazzon E., Vella V., Gangemi P., Vancheri C., Vignen P., Aloisi A., Vigneri R., and Frasca F. The p53-homologue p63 may promote thyroid cancer progression. Endocr.-Relat. Cancer 12 (2005) 953-971
14. Nagase Y., Takata K., Moriyama N., Aso Y., Murakami T., and Hirano H. Immunohistochemical localization of glucose transporters in human renal cell carcinoma. J. Urol. 153 (1995) 798-801
15. Noguchi Y., Marat D., Saito A., Yoshigawa T., Doi C., Fukuzawa K., Tsuburaya A., Satoh S., and Ito T. Expression of facilitative glucose transporters in gastric tumors. Hepato-Gastroenterology 46 (1999) 2683-2689
16. Preto A., Reis-Filho J.S., Richardo S., and Soares P. P63 expression in papillary and anaplastic carcinomas of the thyroid gland: lack of an oncogenic role in tumorigenesis and progression. Pathol. Res. Pract. 198 (2002) 449-454
17. Reisser C., Eichhorn K., Herold-Mende C., Born A.I., and Bannasch P. Expression of facilitative glucose transport proteins during development of squamous cell carcinomas of the head and neck. Int. J. Cancer 80 (1999) 194-198
18. Schonberger J., Ruschoff J., Grimm D., Marienhagen J., Rummele P., Meyringer R., Kossmehl P., Hofstaedter F., and Eilles C. Glucose transporter 1 gene expression is related to thyroid neoplasm with an unfavorable prognosis: an immunohistochemical study. Thyroid 12 (2002) 747-754
19. Schwartzenberg-Bar-Yoseph F., Armoni M., and Karnieli E. The tumor suppressor p53 down-regulates glucose transporters GLUT1 and GLUT4 gene expression. Cancer Res. 64 (2004) 2627-2633
20. Unger P., Ewart M., Wang B.Y., Gan L., Kohtz S., and Burstein D.E. Expression of p63 in papillary thyroid carcinoma and in Hashimoto's thyroiditis: a pathologic link?. Hum. Pathol. 34 (2003) 764-769
21. Volante M., Landolfi S., Chiusa L., Palestini N., Motta M., Codegone A., Torchio B., and Papotti M.G. Poorly differentiated carcinomas of the thyroid with trabecular, insular, and solid patterns: a clinicopathologic study of 183 patients. Cancer 100 (2004) 950-957
22. Wang B.Y., Kalir T., Sabo E., Sherman D.E., Cohen C., and Burstein D.E. Immunohistochemical staining of GLUT1 in benign, hyperplastic, and malignant endometrial epithelia. Cancer 88 (2000) 2774-2781
23. Yang A., Kaghad M., and Wand Y. p63, a p53 homolog at 3q27-29 encodes multiple products with transacticating, death-inducing, and dominant-negative activities. Mol. Cell. 2 (1988) 305-316
24. Younes M., Brown R.W., Mody D.R., Fernandez L., and Laucirica R. GLUT1 expression in human breast carcinoma: Correlation with known prognostic markers. Anticancer Res. 21 (2001) 575-578
25. Younes M., Brown R.W., Stephenson M., Gondo M., and Cagle P.T. Overexpression of GLUT1 and GLUT3 in stage I nonsmall cell lung carcinoma is associated with poor survival. Cancer 80 (1997) 1046-1051
26. Younes M., Lechago L.V., and Lechago J. Overexpression of the human erythrocyte glucose transporter occurs as a late event in human colorectal carcinogenesis and is associated with an increased incidence of lymph node metastases. Clin. Cancer Res. 2 (1996) 1151-1154